A counterimmunoelectrophoresis test for Pneumocystis carinii antigenemia was employed to assess the extent of subclinical infection or colonization with this agent in adults with infection, pulmonary disease, or malignancy and in healthy homosexual men. Antigenemia was detected in 6 of 208 (3%) of normal controls, 3 of 28 (11 %) of patients with pulmonary infection, 3 of 33 (9%) of those with chronic lung disease, 1 of 36 (3%) of patients with lung cancer, 7 of 271 (3%) of afebrile subjects with malignancy, 6 of 19 (32%) of febrile patients with malignancy, 2 of 22 (9%) of those with nonpulmonary infection, and 0 of 21 (0%) of healthy young homosexual men. These data suggest that P. carinii is a common commensal or saprophyte that becomes clinically significant only when host defenses are impaired. Antigenemia may occur intermittently during various disease states in the absence of positive clinical signs and should alert the physician to subacute infection or colonization. Treatment appears advisable when clinical data and counterimmunoelectrophoresis results concur.
The need for a dependable noninvasive method for detecting Pneumocystis carinii infection has grown with increasing awareness of the ubiquity of this opportunistic agent. Although it was once believed to be rare and a threat primarily to debilitated infants and acutely immunocompromised patients with malignancy, two independent serological surveys have shown that 80 to 90% of normal children have specific antibody to this organism by 2 to 4 years of age (13, 18) . Numerous postmortem studies of randomly selected adults have shown that the incidence of asymptomatic infection ranges from 0.2 to 8% (20) . The incidence in randomly selected pediatric patients ranges from 0.9% in infants and stillborns to 1% in children under 7 years of age. Adult leukemia-lymphoma patients exhibited a postmortem incidence of P. carinii infection of 4.7% (6) . The incidence of P. carinii pneumonia (PCP) in children in cancer referral hospitals was 13.3 and 5.6%, respectively (15, 21) . Recent studies have shown that P. carinii was responsible for 18% of mixed or single-agent pneumonias in normal infants less than 3 years of age (22, 23) .
The recent increase in the incidence of frequently fatal Pneumocystis infections among acquired-immunodeficiency syndrome patients, some of whom exhibit Kaposi's sarcoma (4) , intravenous drug abusers (3) and intimate contacts of such individuals (11), hemophiliacs (12), Haitians (1), and infants (2) has emphasized the fact that this agent is considerably more common than previously supposed.
In 1978, Pifer et al. described a counterimmunoelectrophoresis (CIE) test that detects soluble P. carinii antigen(s) in the peripheral circulation (18) . The test was 95% positive in histologically documented cases, yielded no positive results in 100 normal children, and suggested the presence of subclinical P. carinii infection in 15% of 100 randomly selected pediatric patients with cancer.
The ultimate purpose of the present study was to assess the incidence of latent P. carinii infections in adult patients with and without malignancy, infection, or chronic lung Clinical data gathered on these patients included history, temperature on admission, hematological profile (leukocytes, hematocrit, differential, and platelets), urinalysis, albumin, globulin, serum protein electrophoresis, blood urea nitrogen, sodium, calcium, potassium, HCO3, liver function studies, blood gases, blood, sputum and spinal fluid cultures, chest films, any special X-rays or other studies, and drug regimens.
Coded blood specimens were sent to the laboratory where the sera were electrophoresed with antisera raised in rabbits against cell culture-grown P. carinii organisms as described in detail previously (1, 17 The results of previous studies indicated that on the basis of antigenemia data, subclinical infections with P. carinii are considerably more common than previously recognized (13, 18) . It was further shown that afebrile ambulatory adult cancer patients and those with lung cancer without hyperthermia were no more likely than ostensibly healthy adults to exhibit antigenemia (16) . Approximately one-third of the patients with malignancy hospitalized for febrile episodes were found to be antigenemic (19) . Nine percent of the individuals without malignancy but with febrile nonpulmonary infections, 9% of those with pulmonary disease (chronic obstructive pulmonary disease, asthma, etc.), and 11% of the febrile patients with pulmonary infections had relative incidences of antigenemia that did not exceed that observed in normal individuals by more than 8% (16) .
It is important to attempt to answer in such a survey whether false-positive CIE results occurred in the study.
Since biopsy was unfeasible in this survey, as is frequently the case in clinical practice, a definitive answer is not possible. Interpretation of the data must consider such factors as (i) specificity of the antiserum employed in the test, (ii) CIE data derived from biopsy-documented cases of Pneumocystis infection, (iii) serological data, (iv) epidemiological data, and (v) clinical data.
Antigen-antibody specificity with regard to P. carinii has been well documented (17, 18) . The Centers for Disease Control recently verified the specificity of the CIE test for P. carinii antigenemia and corroborated our conclusion that subclinical infections with this agent are more common than previously believed (9, 10). The Centers for Disease Control group has not, however, achieved with the CIE test a level of sensitivity comparable to that obtained by our methods (9, 10 (13, 18) . In addition, nearly 80% of the lymphocytes in normal adults exhibit a positive proliferative response to P. carinii antigen (7). Over 3,000 postmortems on randomly selected adults revealed that an average of 3.3% of these individuals were asymptomatically colonized with P. carinii, as demonstrated by the presence of P. carinii cysts in stained lung sections (20) . In the present study, 3% of adult controls exhibited antigenemia. In cancer patients, 4.7% of adults and 5.6 to 13.3% of the children without clinical PCP had these organisms in lung tissue at postmortem (20) . These values are highly consistent with the incidence of positive CIE tests in both adult and pediatric patients with cancer (14, 18) . These data confirm an earlier report that cell-mediated immunity is apparently of primary importance in maintaining resistance to P. carinii, since substantially high antibody titers do not appear to confer clinical immunity (18) .
With regard to clinical data, incidence of biopsy-or autopsy-proven P. carinii infection, with or without symptoms, increases in direct proportion to the compromise of immunological defenses (8) . It is therefore not surprising that the incidence of antigenemia follows a similar pattern. In conclusion, the most likely interpretation of these data is that P. carinii is a latent commensal opportunist that may begin to increase in numbers as cell-mediated immune defenses undergo compromise. This is usually ultimately evidenced by appearance of antigen in the peripheral circulation.
That patients in group 3 (febrile with nonpulmonary infection) and 4 (afebrile with chronic lung disease) (9%) and also in group 2 (febrile with pulmonary infection) (11%) showed a threefold to nearly fourfold increase, respectively, in antigen positivity, suggests that nonspecific responses That CIE tests on homosexual individuals were all negative is not surprising in that all were healthy young men without any significant clinical symptomatology, despite the fact that, statistically, they belong to a higher-risk group. Acquired immune deficiency syndrome and associated clinical manifestations occur more frequently in people living in certain major metropolitan areas (4) . These data show that these subjects are no more likely to exhibit P. carinii antigenemia than are controls. Group 7, which had the highest percentage of antigenpositive subjects, is of greatest clinical concern. A number of these individuals were in relapse and were having difficulty with infections (ranging from urinary tract infections to sepsis), all of which provoked febrile responses. Although many had pneumonia, none developed acute PCP.
In conclusion, these data suggest that P. carinii is a common infectious agent that becomes clinically significant primarily when host defenses are impaired, i.e., in 
